NSE:ASTRAZEN (India)
Â
Shs Dematerialised
₹
8,310.5
+68.5 (+0.83%)
Jul 3
AstraZeneca Pharma India Ltd Valuation Measures
Fundamental (50)
Valuation Ratio (87)
Profitability (8)
Price (22)
Dividends (7)
Income Statement (47)
Balance Sheet (85)
Cashflow statement (66)